Skip to content

Studies on Alterations in Brain Function after Alcohol Administration Using MRI

Studies on Alterations in Brain Function after Alcohol Administration Using MRI - Studies on Alterations in Brain Function after Alcohol Administration Using MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000032753
Enrollment
24
Registered
2018-05-29
Start date
2019-05-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Alcohol clamping method Alcohol clamping method Wash out Controlled Trial

Sponsors

HUMA R&D CORP
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Age: 20 years or older, less than 30 years 2.Gender: Healthy Japanese men and women without disease 3.Right-handed person 4.Nonsmoker 5.Person who drink alcohol more frequently than once or twice a month. 6.Individuals with ALDH2 alcohol-susceptibility genes *1/*2

Exclusion criteria

Exclusion criteria: 1.Patients with serious or past medical conditions of the heart, liver or kidney 2.Persons currently receiving continuous treatment with drugs 3.Persons with a history of drug or food allergy 4.Patients who are or have a history of treatment for drug dependence or abuse 5.Persons whose working hours are irregular, such as those who have worked at night 6.Subjects who are currently participating in another clinical study or have participated in another clinical study within the previous 3 months 7.Persons using cardiac pacemakers 8.Persons using vascular clips 9.Those using nerve electrical stimulators 10.Persons using implantable pumps 11.Persons in whom a piece of metal is in the body for some reason (including accidents and injuries) 12.Persons with tattoos (including one-point tattoos) 13.Persons with internal metal plates or screws for prostheses such as fractures 14.Other than the above, the investigator considered inappropriate for participation in the study

Design outcomes

Primary

MeasureTime frame
MRI-measured data (T1, DTI, 1H-MRS, resting fMRI) VAS score for subjective symptoms of drunkenness

Secondary

MeasureTime frame
Ethanol Acetaldehyde Acetic acid Lactic acid Pyruvic acid Hematocrit Plasma glucose Plasma vasopressin Plasma TGFBeta Plasma amino acid

Countries

Japan

Contacts

Public ContactDaisuke Ochitani

HUMA R&D CORP Clinical Development Division

ochitani@huma-rd.co.jp81-3-3431-1260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026